KR950700334A - 황산화 다당류, 이들의 제조, 제약학적 조성물 및 이들의 사용(Sulphated polysaccharides, preparation thereof, pharmaceuticalcomposition and use thereof) - Google Patents
황산화 다당류, 이들의 제조, 제약학적 조성물 및 이들의 사용(Sulphated polysaccharides, preparation thereof, pharmaceuticalcomposition and use thereof)Info
- Publication number
- KR950700334A KR950700334A KR1019940702715A KR19940702715A KR950700334A KR 950700334 A KR950700334 A KR 950700334A KR 1019940702715 A KR1019940702715 A KR 1019940702715A KR 19940702715 A KR19940702715 A KR 19940702715A KR 950700334 A KR950700334 A KR 950700334A
- Authority
- KR
- South Korea
- Prior art keywords
- preparation
- sulphated polysaccharides
- pharmaceuticalcomposition
- pharmaceutical compositions
- sulphated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9201383A FR2687158B1 (fr) | 1992-02-07 | 1992-02-07 | Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation. |
| PCT/FR1993/000114 WO1993016112A1 (fr) | 1992-02-07 | 1993-02-04 | Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950700334A true KR950700334A (ko) | 1995-01-16 |
Family
ID=9426428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940702715A KR950700334A (ko) | 1992-02-07 | 1994-08-06 | 황산화 다당류, 이들의 제조, 제약학적 조성물 및 이들의 사용(Sulphated polysaccharides, preparation thereof, pharmaceuticalcomposition and use thereof) |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0625166B1 (ko) |
| JP (1) | JP3218039B2 (ko) |
| KR (1) | KR950700334A (ko) |
| AT (1) | ATE157991T1 (ko) |
| AU (1) | AU671817B2 (ko) |
| CA (1) | CA2126241C (ko) |
| DE (1) | DE69313826T2 (ko) |
| DK (1) | DK0625166T3 (ko) |
| ES (1) | ES2109478T3 (ko) |
| FI (1) | FI106034B (ko) |
| FR (1) | FR2687158B1 (ko) |
| GR (1) | GR3024695T3 (ko) |
| HU (1) | HU214327B (ko) |
| MX (1) | MX9300584A (ko) |
| NO (1) | NO307466B1 (ko) |
| NZ (1) | NZ249165A (ko) |
| WO (1) | WO1993016112A1 (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| US5763427A (en) * | 1995-03-31 | 1998-06-09 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| US6001820A (en) * | 1995-03-31 | 1999-12-14 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| EP0735050B1 (en) * | 1995-03-31 | 2002-09-25 | Hamilton Civic Hospitals Research Development, Inc. | Compositions for inhibiting thrombogenesis |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
| US6075013A (en) * | 1997-06-06 | 2000-06-13 | Hamilton Civic Hospitals Research Development Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
| JP4828795B2 (ja) | 2002-03-11 | 2011-11-30 | モメンタ ファーマシューティカルズ インコーポレイテッド | 硫酸化多糖類の分析 |
| EP2404939A3 (en) | 2006-05-25 | 2012-03-21 | Momenta Pharmaceuticals, Inc. | Low molecular weight heparin composition and uses thereof |
| US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
| CA3020369C (en) * | 2010-09-14 | 2019-11-26 | University Of Miyazaki | High purity heparin and production method therefor |
| WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2945595A1 (de) * | 1979-11-12 | 1981-05-21 | Sandoz-Patent-GmbH, 7850 Lörrach | Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen |
| FR2622450B1 (fr) * | 1987-11-03 | 1991-02-22 | Sanofi Sa | Association heparine/dermatane sulfate |
| EP0337327A1 (en) * | 1988-04-09 | 1989-10-18 | Bioiberica, S.A. | Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin |
| FR2663639B1 (fr) * | 1990-06-26 | 1994-03-18 | Rhone Poulenc Sante | Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation. |
| FR2675806B1 (fr) * | 1991-04-23 | 1994-06-10 | Rhone Poulenc Rorer Sa | Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation. |
-
1992
- 1992-02-07 FR FR9201383A patent/FR2687158B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-03 MX MX9300584A patent/MX9300584A/es not_active IP Right Cessation
- 1993-02-04 AU AU35051/93A patent/AU671817B2/en not_active Expired
- 1993-02-04 DE DE69313826T patent/DE69313826T2/de not_active Expired - Lifetime
- 1993-02-04 NZ NZ249165A patent/NZ249165A/en unknown
- 1993-02-04 WO PCT/FR1993/000114 patent/WO1993016112A1/fr active IP Right Grant
- 1993-02-04 ES ES93904154T patent/ES2109478T3/es not_active Expired - Lifetime
- 1993-02-04 AT AT93904154T patent/ATE157991T1/de active
- 1993-02-04 DK DK93904154.7T patent/DK0625166T3/da active
- 1993-02-04 JP JP51382593A patent/JP3218039B2/ja not_active Expired - Fee Related
- 1993-02-04 EP EP93904154A patent/EP0625166B1/fr not_active Expired - Lifetime
- 1993-02-04 CA CA002126241A patent/CA2126241C/fr not_active Expired - Lifetime
- 1993-02-04 HU HU9401994A patent/HU214327B/hu not_active IP Right Cessation
-
1994
- 1994-08-04 NO NO942897A patent/NO307466B1/no not_active IP Right Cessation
- 1994-08-05 FI FI943642A patent/FI106034B/fi not_active IP Right Cessation
- 1994-08-06 KR KR1019940702715A patent/KR950700334A/ko not_active Application Discontinuation
-
1997
- 1997-09-11 GR GR970400825T patent/GR3024695T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO307466B1 (no) | 2000-04-10 |
| FR2687158A1 (fr) | 1993-08-13 |
| AU3505193A (en) | 1993-09-03 |
| FR2687158B1 (fr) | 1995-06-30 |
| DE69313826D1 (de) | 1997-10-16 |
| ES2109478T3 (es) | 1998-01-16 |
| FI106034B (fi) | 2000-11-15 |
| DE69313826T2 (de) | 1998-02-12 |
| NZ249165A (en) | 1996-01-26 |
| CA2126241C (fr) | 2004-06-22 |
| HU214327B (hu) | 1998-03-02 |
| HUT67878A (en) | 1995-05-29 |
| ATE157991T1 (de) | 1997-09-15 |
| AU671817B2 (en) | 1996-09-12 |
| GR3024695T3 (en) | 1997-12-31 |
| MX9300584A (es) | 1993-08-01 |
| NO942897D0 (ko) | 1994-08-04 |
| NO942897L (no) | 1994-08-04 |
| HU9401994D0 (en) | 1994-09-28 |
| JPH07503496A (ja) | 1995-04-13 |
| EP0625166A1 (fr) | 1994-11-23 |
| EP0625166B1 (fr) | 1997-09-10 |
| WO1993016112A1 (fr) | 1993-08-19 |
| DK0625166T3 (da) | 1998-02-02 |
| JP3218039B2 (ja) | 2001-10-15 |
| CA2126241A1 (fr) | 1993-08-19 |
| FI943642A (fi) | 1994-08-05 |
| FI943642A0 (fi) | 1994-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL61201A (en) | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them | |
| IL98604A0 (en) | Mixtures of low molecular weight polysaccharides,their preparation and pharmaceutical compositions containing them | |
| DK472587D0 (da) | Polysaccharidkompositioner | |
| NO307835B1 (no) | Ikke-farmasøytisk polysakkaridkonjugat | |
| IT8921066A0 (it) | Composizioni polimeriche autoestinguenti. | |
| IL100229A0 (en) | N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them | |
| AU627615B2 (en) | Self-extinguishing polymeric compositions | |
| KR950700334A (ko) | 황산화 다당류, 이들의 제조, 제약학적 조성물 및 이들의 사용(Sulphated polysaccharides, preparation thereof, pharmaceuticalcomposition and use thereof) | |
| IL93490A0 (en) | Pharmaceutical compositions comprising ranitidine | |
| BR9100297A (pt) | Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes | |
| IT1238685B (it) | Polisaccaridi ad azione immunomodulatrice da astragalus membranaceous e composizioni farmaceutiche che li contengono | |
| NZ234595A (en) | N-aryl arylamide derivatives and pharmaceutical compositions thereof | |
| ZA922874B (en) | Sulphated polysaccharides,their preparation,pharmaceutical compositions containing them and their use | |
| NZ212915A (en) | 9-oxo-15-alpha-hydroxy-16-(substituted) phenoxy-17,18,19,20-tetranorprosta-4,5,13(e)-triene prostaglandins and pharmaceutical compositions | |
| IL93719A0 (en) | (5(6)(benzisoxa-benzisothia-or indazol-3-yl)-1h-benzimidazol-2-yl)carbamates,their preparation and pharmaceutical compositions containing them | |
| GB8907057D0 (en) | Polysaccharide compositions | |
| IT9021332A0 (it) | Expolimero ottenuto a partire da ceppi selezionati del genere bifidobacterium, suo procedimento di preparazione e composizioni farmaceutiche che lo contengono | |
| IT8721958A0 (it) | Derivato di taurina, sua preparazione e composizioni farmaceutiche relative | |
| ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge | |
| IL70406A (en) | Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin | |
| NZ236473A (en) | 2,19-methyleneoxy and 2,19-methylenethio bridged steroids and pharmaceutical compositions | |
| IT9022115A0 (it) | Nuovi derivati di selenofene, un procedimento per la loro preparazionee composizioni che li contengono | |
| IT8622051A0 (it) | Composizioni farmaceutiche adattivita' cicatrizzante. | |
| IT8921562A0 (it) | Composizioni polimeriche autoestinguenti. | |
| IT8224440A0 (it) | Nuovo derivato di 2,3-benzodiazina e relative composizioni farmaceutiche. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |